gymnema sylvestre glp-1 study Mapping the effectiveness and risks of receptor agonists GLP-1 Genetics: How Genes Affect

The FDA labeling for Wegovy, Saxenda, and Zepbound includes warnings about monitoring for depression, suicidal thoughts, and suicidal behavior, which is particularly relevant for patients already taking antidepressants

18 They found that patients taking semaglutide were more likely to develop NAION at two, three and four years after initiation of treatment, with a cumulative HR of 2.22 after four years compared to control (n=45 vs 29)

You can request a physical card to be mailed to you, or you can simply request a digital card by text

All GLP-1 medications start low and gradually increase every 4 weeks (weekly formulations) or weekly (daily formulations) to minimize gastrointestinal side effects

Greer B

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al